Doubt over Sanofi drug in EU may hurt wider MS market
LONDON (Reuters) - Uncertainty over European exclusivity for Sanofi's new multiple sclerosis (MS) pill Aubagio could disrupt the wider market and impa...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/2PqmQCjae_E/story01.htm
No comments:
Post a Comment